Q32 Bio Inc. Segment Reporting Other Item Amount
Q32 Bio Inc. (QTTB) reported Segment Reporting Other Item Amount of $1.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-05
- Q32 Bio Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $1.86M, a 7.40% decline year-over-year.
- Q32 Bio Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $1.77M, a 129.31% increase year-over-year.
- Q32 Bio Inc. segment reporting other item amount for the quarter ending 2025-12-31 was -$63.87M.
- Q32 Bio Inc. segment reporting other item amount for the quarter ending 2025-09-30 was $1.32M, a 0.77% increase year-over-year.
- Q32 Bio Inc. segment reporting other item amount for fiscal 2025 was -$59.84M.
- Q32 Bio Inc. segment reporting other item amount for fiscal 2024 was -$9.98M, a 163.78% decline from fiscal 2023.
- Q32 Bio Inc. segment reporting other item amount for fiscal 2023 was $15.64M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.86M 10-Q · filed 2026-08-05 | $3.63M 10-Q · filed 2026-08-05 | -$60.23M derived: sum of 3 quarters · filed 2026-08-05 | -$58.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.77M 10-Q · filed 2026-05-05 | -$62.10M derived: sum of 2 quarters · filed 2026-05-05 | -$60.78M derived: sum of 3 quarters · filed 2026-05-05 | -$58.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$63.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$62.55M derived: sum of 2 quarters · filed 2026-03-10 | -$60.53M derived: sum of 3 quarters · filed 2026-08-05 | -$59.84M 10-K · filed 2026-03-10 |
| 2025-09-30 | $1.32M 10-Q · filed 2025-11-13 | $3.33M derived: sum of 2 quarters · filed 2026-08-05 | $4.03M 10-Q · filed 2025-11-13 | -$17.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.01M 10-Q · filed 2026-08-05 | $2.71M 10-Q · filed 2026-08-05 | -$19.22M derived: sum of 3 quarters · filed 2026-08-05 | -$17.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $771.00K 10-Q · filed 2026-05-05 | -$21.24M derived: sum of 2 quarters · filed 2026-05-05 | -$19.93M derived: sum of 3 quarters · filed 2026-05-05 | -$18.24M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$22.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$20.70M derived: sum of 2 quarters · filed 2026-03-10 | -$19.01M derived: sum of 3 quarters · filed 2026-03-10 | -$9.98M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.31M 10-Q · filed 2025-11-13 | $3.00M derived: sum of 2 quarters · filed 2025-11-13 | $12.03M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.69M 10-Q · filed 2025-08-06 | -$13.33M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | -$15.00M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $15.64M 10-K · filed 2025-03-11 |